Clinical trial Recruiting at 1 site Interventional Ages 18 to 55 Women only

Separating maternal and fetal heart signals from abdominal ECG

Official title: The Development and Validation of Maternal and Fetal Electrocardiograms (ECG) Separation Algorithm Based on Artificial Intelligence Application

Run by I.M. Sechenov First Moscow State Medical University · NCT07518550 · Data updated 2026-11-12

We will test a computer algorithm that extracts a baby's heartbeat from noninvasive belly ECG recordings in pregnant women during the second and third trimesters.

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexWomen only
Enrollment350 (estimated)
SponsorI.M. Sechenov First Moscow State Medical University
Academic / other
Locations1 site (Moscow)
StatusRecruiting
StartedFebruary 12, 2026
Main results expectedJanuary 20, 2027
Study endsMay 30, 2028
Registry record updatedApril 8, 2026
Trial IDNCT07518550 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women over 18 years old with a singleton pregnancy in the second or third trimester who can sit for at least 5 minutes and provide informed consent.

Probably not a fit

Women with multiple pregnancies, severe maternal or fetal conditions, those under 18, or those outside the second and third trimesters are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect at least 300 abdominal ECG recordings using wearable textile electrodes from women in their second and third trimesters, with each recording lasting 5–10 minutes under standardized conditions. Signal features will be analyzed by gestational stage and compared with clinical information to characterize maternal and fetal rhythm overlap. Machine learning methods and independent component analysis will be used to develop an adaptive algorithm tuned for trimester-specific physiology, followed by validation on a separate cohort of 50 patients. The goal is to improve the accuracy and reliability of automatic fetal heartbeat detection from noninvasive abdominal recordings.

Why it matters

Potential benefit: If successful, the algorithm could enable faster and more accurate noninvasive detection of fetal heartbeats, improving routine fetal monitoring during pregnancy.

How similar studies have gone: Similar methods using independent component analysis and machine learning have shown promising but variable results in extracting fetal ECG noninvasively, and applying these techniques with wearable, trimester-adaptive algorithms is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age over 18 years
* Recordings obtained during the second or third trimester of pregnancy
* Recording duration of at least 5 minutes
* Singleton pregnancy
* Signed informed consent

Exclusion Criteria:

* Age under 18 years;
* Multiple pregnancy;
* Recent medical procedures or interventions that could affect the quality of electrocardiographic data;
* Severe maternal conditions (e.g., severe eclampsia, shock, severe organ failure, etc.);
* Severe fetal conditions (e.g., significant hypoxia, severe placental-fetal syndrome, and other life-threatening states).

Exclusion criteria:

1\. Patient's refusal to continue participation in the study.

Where it's running

  • V.F. Snegirev Clinic of Obstetrics and Gynecology of I.M. Sechenov First Moscow State Medical University
    Moscow, Russia
    Recruiting

Study contacts

  • Principal investigator: Philipp Yu Kopylov, Prof. — I.M. Sechenov First Moscow State Medical University (Sechenov University)
  • Study coordinator: Philipp Yu Kopylov, Prof.
  • Email: kopylov_f_yu@staff.sechenov.ru
  • Phone: +7-903-687-72-64

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.